Genetic variability and natural selection at the ligand domain of the Duffy binding protein in brazilian Plasmodium vivax populations


Autoria(s): SOUSA, Tais N.; TARAZONA-SANTOS, Eduardo M.; WILSON, Daniel J.; MADUREIRA, Ana P.; FALCAO, Paula R. K.; FONTES, Cor J. F.; GIL, Luiz H. S.; Ferreira, Marcelo Urbano; CARVALHO, Luzia H.; BRITO, Cristiana F. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

18/04/2012

18/04/2012

2010

Resumo

Background: Plasmodium vivax malaria is a major public health challenge in Latin America, Asia and Oceania, with 130-435 million clinical cases per year worldwide. Invasion of host blood cells by P. vivax mainly depends on a type I membrane protein called Duffy binding protein (PvDBP). The erythrocyte-binding motif of PvDBP is a 170 amino-acid stretch located in its cysteine-rich region II (PvDBP(II)), which is the most variable segment of the protein. Methods: To test whether diversifying natural selection has shaped the nucleotide diversity of PvDBP(II) in Brazilian populations, this region was sequenced in 122 isolates from six different geographic areas. A Bayesian method was applied to test for the action of natural selection under a population genetic model that incorporates recombination. The analysis was integrated with a structural model of PvDBP(II), and T-and B-cell epitopes were localized on the 3-D structure. Results: The results suggest that: (i) recombination plays an important role in determining the haplotype structure of PvDBP(II), and (ii) PvDBP(II) appears to contain neutrally evolving codons as well as codons evolving under natural selection. Diversifying selection preferentially acts on sites identified as epitopes, particularly on amino acid residues 417, 419, and 424, which show strong linkage disequilibrium. Conclusions: This study shows that some polymorphisms of PvDBP(II) are present near the erythrocyte-binding domain and might serve to elude antibodies that inhibit cell invasion. Therefore, these polymorphisms should be taken into account when designing vaccines aimed at eliciting antibodies to inhibit erythrocyte invasion.

Microsoft Corporation

National Research Council from Brazil (CNPq)

Minas Gerais State Foundation in Aid of Research (FAPEMIG)

Brazilian Ministry of Education (CAPES Agency)

Identificador

MALARIA JOURNAL, LONDON, v.9, 2010

1475-2875

http://producao.usp.br/handle/BDPI/15905

10.1186/1475-2875-9-334

http://dx.doi.org/10.1186/1475-2875-9-334

Idioma(s)

eng

Publicador

BIOMED CENTRAL LTD

LONDON

Relação

Malaria Journal

Direitos

openAccess

Copyright BIOMED CENTRAL LTD

Palavras-Chave #APICAL MEMBRANE ANTIGEN-1 #BLOOD-GROUP #DIVERSIFYING SELECTION #INHIBITORY ANTIBODIES #STATISTICAL TESTS #DNA POLYMORPHISM #AMAZON REGION #MALARIA #KNOWLESI #RECEPTOR #Parasitology #Tropical Medicine
Tipo

article

original article

publishedVersion